These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 20435178)

  • 1. Evaluation of ventricular arrhythmias in early clinical pharmacology trials and potential consequences for later development.
    Min SS; Turner JR; Nada A; DiMino TL; Hynie I; Kleiman R; Kowey P; Krucoff MW; Mason JW; Phipps A; Newton-Cheh C; Pordy R; Strnadova C; Targum S; Uhl K; Finkle J
    Am Heart J; 2010 May; 159(5):716-29. PubMed ID: 20435178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequencies and types of arrhythmias in patients with systemic light-chain amyloidosis with cardiac involvement undergoing stem cell transplantation on telemetry monitoring.
    Goldsmith YB; Liu J; Chou J; Hoffman J; Comenzo RL; Steingart RM
    Am J Cardiol; 2009 Oct; 104(7):990-4. PubMed ID: 19766769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrocardiographic monitoring of patients receiving phase I cancer chemotherapy.
    Hersh MR; Linn W; Kuhn JG; Von Hoff DD
    Cancer Treat Rep; 1986 Mar; 70(3):349-52. PubMed ID: 3955546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative strategies in drug development: clinical pharmacological aspects.
    Kuhlmann J
    Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current challenges in the evaluation of cardiac safety during drug development: translational medicine meets the Critical Path Initiative.
    Piccini JP; Whellan DJ; Berridge BR; Finkle JK; Pettit SD; Stockbridge N; Valentin JP; Vargas HM; Krucoff MW;
    Am Heart J; 2009 Sep; 158(3):317-26. PubMed ID: 19699852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of patients at risk for sudden heart death by long-term ECG. The role of life-threatening ventricular arrhythmias].
    Hombach V; Höpp HW; Osterspey A; Winter U; Deutsch H; Hilger HH
    Herz; 1984 Feb; 9(1):6-25. PubMed ID: 6200415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. If a drug deemed 'safe' in nonclinical tests subsequently prolongs QT in phase 1 studies, how can its sponsor convince regulators to allow development to proceed?
    Shah RR
    Pharmacol Ther; 2008 Aug; 119(2):215-21. PubMed ID: 18455801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are the American College of Cardiology/Emergency Cardiac Care (ACC/ECC) guidelines useful in triaging patients to telemetry units?
    Tiongson J; Robin J; Chana A; Shin DD; Gheorghiade M
    Acute Card Care; 2006; 8(3):155-60. PubMed ID: 17012130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Introduction of anticancer agents to phase I clinical trials].
    Shimoyama M
    Gan To Kagaku Ryoho; 1997 Jan; 24(2):246-55. PubMed ID: 9030238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation and treatment of ventricular arrhythmias: an update.
    McCollam PL; Parker RB
    Clin Pharm; 1991 Mar; 10(3):195-205. PubMed ID: 2040126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of drug-induced increases in blood pressure during drug development: report from the Cardiac Safety Research Consortium.
    Sager P; Heilbraun J; Turner JR; Gintant G; Geiger MJ; Kowey PR; Mansoor GA; Mendzelevski B; Michelson EL; Stockbridge N; Weber MA; White WB
    Am Heart J; 2013 Apr; 165(4):477-88. PubMed ID: 23537963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The predictive value for major arrhythmic events of ventricular arrhythmias, particularly nonsustained ventricular tachycardias, in the subacute phase of a fibrinolyzed infarct. An analysis of GISSI-2 data. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico].
    Giani P; Avanzini F; Bagliani G; Galati A; Pucci P; Santoro E
    G Ital Cardiol; 1995 Jan; 25(1):77-87. PubMed ID: 7642014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Methodology in clinical trials of anti-arrhythmia agents in ventricular arrhythmias. Analysis and perspective following results of the CAST study].
    Jaillon P; Dupuis B
    Arch Mal Coeur Vaiss; 1991 Feb; 84 Spec No 2():35-40. PubMed ID: 1669238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrocardiographic assessment for therapeutic proteins--scientific discussion.
    Rodriguez I; Erdman A; Padhi D; Garnett CE; Zhao H; Targum SL; Balakrishnan S; Strnadova C; Viner N; Geiger MJ; Newton-Cheh C; Litwin J; Pugsley MK; Sager PT; Krucoff MW; Finkle JK
    Am Heart J; 2010 Oct; 160(4):627-34. PubMed ID: 20934555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Minimizing the risks associated with QTc prolongation in people with schizophrenia. A consensus statement by the Cardiac Safety in Schizophrenia Group].
    Ames D; Camm J; Cook P; Falkai P; Gury C; Hurley R; Johnson G; Piepho R; Vieweg V;
    Encephale; 2002; 28(6 Pt 1):552-62. PubMed ID: 12506268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive diagnosis of ventricular arrhythmias by means of ambulatory-ECG monitoring.
    Candinas RA; Podrid PJ
    Herz; 1990 Feb; 15(1):1-10. PubMed ID: 2179087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ethics of phase 0 oncology trials.
    Abdoler E; Taylor H; Wendler D
    Clin Cancer Res; 2008 Jun; 14(12):3692-7. PubMed ID: 18559585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring and safety assessment in Phase I to III clinical trials.
    Fescharek R; Nicolay U; Arras-Reiter C
    Dev Biol Stand; 1998; 95():203-9. PubMed ID: 9855433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term electrocardiographic safety monitoring in clinical drug development: A report from the Cardiac Safety Research Consortium.
    Piccini JP; Clark RL; Kowey PR; Mittal S; Dunnmon P; Stockbridge N; Reiffel JA; Turakhia MP; Ziegler PD; Kleiman RB; Ismat F; Sager P
    Am Heart J; 2017 May; 187():156-169. PubMed ID: 28454799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.